ArticleiScience2026
High glucose diet induces hepatic iron overload contributing to metabolic dysfunction.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- PFOS and PFOA exposure induces liver injury and sex-dependent immune effects in C57BL/6 mice.iScience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Iron is an essential biometal, critical in processes that include oxygen transport, mitochondrial respiration, and cell signaling. Iron dyshomeostasis is linked with hyperglycemia and associated metabolic disorders, but the underlying mechanisms are poorly understood. To investigate these mechanisms, we conducted a 4-week study on mice given glucose-supplemented water. The supplementation induced metabolic shifts in the liver towards triglyceride synthesis. We tracked iron trafficking by analyzing liver and serum markers of iron metabolism alongside iron speciation analysis as determined by liquid chromatography with inductively-coupled plasma mass spectrometry (LC-ICP-MS). Glucose supplementation induced changes in iron regulation despite equal dietary iron intake. Specifically, we observed increased uptake of transferrin-bound iron and liver iron overload. We developed cell-based models recapitulating this state. Metformin restored iron regulation while the iron chelator, deferoxamine, restored glucose metabolism. Taken together, our studies reveal that early hyperglycemia disrupts iron homeostasis, identifying iron overload as a viable therapeutic target in metabolic dysfunction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.